Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: The three western U.S. cities top the list of the 100 best towns for men in a new ranking compiled by Men's Health magazine, while Charleston, West Virginia, Philadelphia and Birmingham, Alabama are considered the worst. "Anytime we do a best and worst city ranking and a city comes in at the very top like this, it immediately says to us they were consistently strong across the board in pretty much all of the 38 criteria that we looked at," Men's Health Executive Editor Matt Marion said. Boise, which jumped from fifth place last year, scored high marks for the physical and mental health of its residents, its low crime rate and short commuting times - an average of just 18 minutes. "Boise finishing number one was interesting to us because it is a city that would have finished in the top 20, but to come in right at the top is impressive," Marion said. San Francisco, which consistently ranks high in the annual list, impressed with its small percentage of obese people, low number of smokers and highly educated and generally fit population. San Jose had very low death rates from cancer and heart disease, the lowest percentage of smokers in any of the 100 cities in the ranking, and not much crime. Plano, in Texas and Seattle rounded out the top five, followed by Burlington, Vermont, which dropped from the top spot last year. At the opposite end of the list, high cancer rates, violent crime and poor fitness levels assured Birmingham last place. In addition to Philadelphia and Charleston, West Virginia, the bottom five included Toledo, Ohio and St. Louis, Missouri. New York ranked 33rd and Los Angeles was in the middle of the ranking. The magazine compiled the list, now in its 12th year, by ranking the cities on criteria ranging from the cost of living, number of jobless, obesity, crime and death rates, to air quality and the ratio of men to women. It used data from various sources including the U.S. Centers for Disease Control in Atlanta, the National Center for Health Statistics, state cancer registries and federal crime statistics. "The things that we do focus on ultimately are the ones that will make a difference in terms of whether or not you will be happy and healthy," Marion said. The full list can be found here Claim: Idaho, California cities deemed best in U.S. for men.
U.S. men looking for the best place to find happiness, health and a good quality of life might consider heading to Boise, Idaho, or San Jose and San Francisco in northern California.

Paragraph: The drones will spray a silicone-based liquid on rice paddies, where there are large expanses of stagnant water where malaria-carrying mosquitoes lay their eggs. The substance will spread across the water and prevent the eggs from hatching. It is hoped this will significantly reduce the numbers of the malaria-carrying anopheles mosquitoes in the area. The spraying by drones is a test to see if it will help the government of Zanzibar reach its goal of eliminating malaria on the archipelago by 2023, according to the strategic plan adopted by Zanzibar Malaria Elimination Program. The drone spraying is a relatively inexpensive way to stop the mosquitoes from reproducing, said Bart Knols, a medical entomologist and lead researcher of the program. "We are getting to the bottom of it as we will spray the breeding grounds of mosquitoes," said Knols, who is with the Dutch Malaria Foundation. The drone will spray Aquatain, a liquid gel that will spread over a section of water and kill mosquitoes' larvae, said Knols. The substance has been tested internationally and has been found to be harmless to non-target organisms, non-toxic and biodegradable. In the initial test, in the Cheju area of southern Zanzibar, the drone flew over and sprayed the shallow, sunlit water bodies in the rice paddies teeming with mosquito larvae, which were trapped as the gel spread across the water. Without the gel, the larvae would have emerged as adult mosquitoes in search of a blood meal. When those mosquitoes bite humans infected with malaria, they become vectors for the disease and continue its deadly transmission cycle. Along the Indian Ocean coast of East Africa, Zanzibar and mainland Tanzania have had a long, well-documented battle with malaria. In the last 10 years, Zanzibar, with a population of 1.2 million people, has embarked on different methods of fighting malaria. Thousands of mosquito nets have been distributed to put over beds and insecticide was supplied to spray in homes. The campaigns have succeeded in decreasing the disease's prevalence. Some areas of Zanzibar have seen the prevalence of malaria drop from 40% of the population to less than 10%, according to the malaria elimination program. The spraying by drones is a new part of the strategy. The use of drones will be essential to efficiently spraying the large rice fields, which have been identified as malaria hot spots on Zanzibar. The drone is efficient because spraying by hand is very time consuming and using a helicopter is too expensive, said Eduardo Rodriguez of DJI, a Chinese drone manufacturer. With the help of drone pilots from the State University of Zanzibar, the DJI Agras drone is being tested to spray the rice paddies. "The ultimate vision of our fight against malaria is to bring malaria down to zero in year 2023 as our target,"said Abdullah Suleiman Ali, manager of the Zanzibar Malaria Elimination Program. ___ Follow Africa news at https://twitter.com/AP_Africa Claim: Zanzibar tests drones spraying rice fields to fight malaria.
For the first time drones are being tested to help fight malaria on the island of Zanzibar, off the coast of Tanzania.

Paragraph: There was no discussion of the potential cost of the drug. Since the story briefly discusses "a similar drug" it could have at least given the cost of that drug. As it is, cost is unaddressed a huge vacuum. The benefits are quantified. Women who received Iniparib plus chemotherapy lived an average of 12.3 months while those receiving chemotherapy alone lived an average of 7.7 months. Tumor volume decreasedin 50% of the women receiving Iniparib & 33% of women receiving only chemotherapy. While the researcher believed the drug was well-tolerated, the article should have included information about demonstrated side effects, even minor ones. The author also should have noted if the study was powered to detect differences since the study cohort was so small. The evaluation of the evidence was good. The piece included cautionary quotes from the researcher. Quotes from a journal editorial also specified drawbacks of the study. Three of the four drawbacks listed were not explained in the piece. Explanations would have been helpful especially since the piece termed the chemotherapy regimen "commonly used" but one drawback was "the unconventional chemotherapy regimen." There is no disease mongering. The article does not include information about Dr. O'Shaugnessy's funding from the drug company for consulting & travel. Observations from other researchers about the study would have provided needed perspective about the results. Alternative treatments are not mentioned but the piece explains that metastatic triple-negative breast cancer is very difficult to treat & that many currently available treatments are not effective. The story notes that the drug is experimental & that the results reported are from a Phase 2 trial. Results from a larger Phase 3 trial of 500 women will be available in 2-3 months. Information about whether the drug has FDA approval or whether it is currently used for treating other diseases would have been helpful. The piece states that Iniparib is from a new class of drugs called PARP inhibitors. It also notes that a similar drug has shown benefits in women with BRCAI or BRCAII mutations. The piece includes information beyond that available in the press release from Sanofi-Aventis. Claim: Experimental Drug Helps Fight Aggressive Breast Cancer: Report
This article reports on a study and accompanying editorial published in The New England Journal of Medicine. The piece details the results of a Phase 2 trial for the experimental cancer drug Iniparib which was developed to treattriple-negative breast cancer. There were appropriate caveats in the body of the story "we really don't know if this is going to end up benefitting patients""both excitement and caution are appropriate in interpreting the trial""some clear drawbacks should be noted." Metastasized triple-negative breast cancer is difficult to treat. Ifthe results of this study hold up in already ongoing largertrials, PARP inhibitors may be a new class of drugs that might be more effective than current therapies. The story deserves credit for showing restraint in covering the results of this study. However, it would have been better if the story had included morekey details on costs, harms and potential conflicts of interest.